Neurogene (NGNE) Profit After Tax (2013 - 2026)

Neurogene (NGNE) has 14 years of Profit After Tax data on file, last reported at -$30.9 million in Q1 2026.

• Quarterly Profit After Tax fell 36.59% year-over-year to -$30.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$98.7 million (down 22.05% YoY) and the FY2025 annual result came in at -$90.4 million, down 20.3% from the prior year.
• Profit After Tax retreated to -$30.9 million in Q1 2026, from -$24.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $13.7 million in Q4 2023 to a low of -$49.8 million in Q4 2022.
• A 5-year average of -$18.6 million and a median of -$18.5 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2023 — Profit After Tax surged 127.4% — and 2024, when it plunged 242.92%.
• Tracing NGNE's Profit After Tax over 5 years: stood at -$49.8 million in 2022, then soared by 127.4% to $13.7 million in 2023, then sank by 242.92% to -$19.5 million in 2024, then retreated by 27.09% to -$24.8 million in 2025, then retreated by 24.73% to -$30.9 million in 2026.
• The last three Profit After Tax figures came in at -$30.9 million (Q1 2026), -$24.8 million (Q4 2025), and -$21.0 million (Q3 2025), per Business Quant data.